QI
HALO icon

Qtron Investments’s Halozyme HALO Stock Holding History

Qtron Investments’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Hold
7,160
– – 0.06% 345
2025
Q4 		$482K Buy
+7,160
New +$482K 0.06% 335
2021
Q3 		– Sell
-5,624
Closed -$255K – 325
2021
Q2 		$255K Hold
5,624
– – 0.06% 294
2021
Q1 		$234K Buy
+5,624
New +$257K 0.07% 295

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qtron Investments's HALO Position: Q1 2026 in Review

Qtron Investments held its Halozyme (HALO) position steady in Q1 2026 at 7,160 shares worth $463K. The position accounts for 0.06% of the portfolio, ranked #345.

Qtron Investments first reported a position in HALO in Q1 2021 and has held it in 4 quarters since. The position peaked at $482K in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Qtron Investments held 7,160 shares of Halozyme worth $463K as of Q1 2026.
  • Qtron Investments left its Halozyme share count unchanged in Q1 2026.
  • Halozyme made up 0.06% of Qtron Investments's portfolio in Q1 2026, its #345 holding.
  • Qtron Investments first reported a position in Halozyme in Q1 2021 and has held it in 4 quarters since.
  • Qtron Investments's Halozyme position peaked at $482K in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Qtron Investments's 13F filing for Q1 2026, filed 15 May 2026.